Aarti Pharmalabs Limited has informed the Exchange about Schedule of meet
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs has scheduled an earnings conference call for investors and analysts on Wednesday, August 13, 2025, at 4:00 PM IST. The call, hosted by Nuvama Wealth Management, will discuss the company's Q1-FY26 financial results. Management will be represented by Chairman Rashesh Gogri, Vice Chairperson & MD Hetal Gogri Gala, and CFO Piyush Lakhani. International dial-in access is available for India, USA, UK, Singapore, and Hong Kong participants.
This is a routine disclosure under SEBI LODR Regulation 30, indicating the company will share its Q1-FY26 earnings with analysts and investors. No immediate material impact on share price, but the call may provide forward-looking commentary and colour on business performance.